CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 7.35: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.48%Below 5Y avg (4.91%)
Annual Rate
CNY 0.15Paid annual
Payout Ratio
142.9%High
Payback Period
66.1 yr
Last Ex-Dividend
Jun 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.20BCNY777.26M · vs all stocks (USD)
Trailing P/E
68.86xRevenue (TTM)
826.71MCNY123.45M · vs all stocks (USD)
Profit Margin
9.04%Beta
1.34xvs all stocks
52-Week Change
16.28%vs all stocks
Market Capitalization
5.20BCNY777.26M · vs all stocks (USD)
Enterprise Value
4.79BCNY715.51M · vs all stocks (USD)
Trailing P/E
68.86xForward P/E
13.97xPrice to Sales (TTM)
5.99xPrice to Book (MRQ)
2.77xEnterprise to Revenue
5.80xEnterprise to EBITDA
32.70xGross Margin
52.27%Profit Margin
9.04%Operating Margin
4.18%Return on Assets (TTM)
1.96%Return on Equity (TTM)
4.21%Revenue (TTM)
826.71MCNY123.45M · vs all stocks (USD)
Revenue per Share (TTM)
1.55CNYUpdated Sep 21, 2026Quarterly Revenue Growth
-6.40%Gross Profit (TTM)
431.44MCNY64.43M · vs all stocks (USD)
EBITDA (TTM)
61.89MCNY9.24M · vs all stocks (USD)
Net Income (TTM)
74.77MCNY11.17M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-17.00%Operating Cash Flow (TTM)
183.27MCNY27.37M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
106.83MCNY15.95M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1500CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
1.48%vs all stocks
5-Year Average Dividend Yield
4.91%vs all stocks
Payout Ratio
142.86%Revenue
924.53MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
419.51MCNYFY2025 · Dec 31, 2025Gross Profit
505.02MCNYFY2025 · Dec 31, 2025Operating Income
81.90MCNY12.23M · vs all stocks (USD)
Pre-tax Income
82.28MCNYFY2025 · Dec 31, 2025Income Tax Expense
613.25KCNYFY2025 · Dec 31, 2025Net Income
81.67MCNYFY2025 · Dec 31, 2025EBIT
86.52MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
156.10MCNYFY2025 · Dec 31, 2025Research & Development
44.41MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
285.80MCNYFY2025 · Dec 31, 2025Other Operating Expenses
13.93MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.78MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
4.23MCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
81.67MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
148.43MCNYFY2025 · Dec 31, 2025Free Cash Flow
69.09MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
125.64MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
81.67MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.77MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
45.81MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
17.18MCNYFY2025 · Dec 31, 2025Capital Expenditures
-79.35MCNYFY2025 · Dec 31, 2025Sale of Investments
795.56KCNYFY2025 · Dec 31, 2025Other Investing Activity
-210.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-288.55MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
618.95MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-889.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-24.91MCNYFY2025 · Dec 31, 2025Other Financing Charges
162.10MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-132.86MCNYFY2025 · Dec 31, 2025Shares Outstanding
513.31MSharesUpdated Sep 21, 2026Float Shares
305.15MSharesUpdated Sep 21, 2026% Held by Insiders
40.46%vs all stocks
% Held by Institutions
1.09%vs all stocks
Total Cash (MRQ)
556.32MCNY83.07M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.09CNYUpdated Sep 21, 2026Total Debt (MRQ)
424.20MCNY63.35M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2384xCurrent Ratio (MRQ)
1.59xBook Value per Share (MRQ)
3.48CNYUpdated Sep 21, 2026Total Assets
2.31BCNY345.17M · vs all stocks (USD)
Total Current Assets
857.60MCNYFY2025 · Dec 31, 2025Total Liabilities
489.96MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.45BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
35.63MCNYFY2025 · Dec 31, 2025Total Current Liabilities
454.33MCNYFY2025 · Dec 31, 2025Cash
125.64MCNYFY2025 · Dec 31, 2025Cash Equivalents
517.27KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
126.15MCNYFY2025 · Dec 31, 2025Other Short-term Investments
210.00MCNYFY2025 · Dec 31, 2025Accounts Receivable
73.99MCNYFY2025 · Dec 31, 2025Inventory
237.63MCNYFY2025 · Dec 31, 2025Accounts Payable
68.63MCNYFY2025 · Dec 31, 2025Short-term Debt
263.54MCNYFY2025 · Dec 31, 2025Other Current Liabilities
12.84MCNYFY2025 · Dec 31, 2025Common Stock (Book)
513.31MCNYFY2025 · Dec 31, 2025Retained Earnings
399.40MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.82BCNY272.00M · vs all stocks (USD)
Treasury Stock
101.19MCNYFY2025 · Dec 31, 202552-Week Low
7.66CNYUpdated Sep 21, 202652-Week High
15.21CNYUpdated Sep 21, 202652-Week Change
16.28%vs all stocks
Beta
1.34xvs all stocks
50-Day MA
9.19CNYUpdated Sep 21, 2026200-Day MA
10.28CNYUpdated Sep 21, 2026Avg 10-Day Volume
17.34MSharesUpdated Sep 21, 2026Avg 30-Day Volume
16.63MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.1400CNYUpdated Sep 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 7.35: safe zoneNotable
Altman Z-Score: 7.35
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Tibet Duorui Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Pharming Group N.V.
Tier 1ProductionApproval-Gated PipelineRule
Achieve Life Sciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Gyre Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tong Ren Tang Technologies Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Heilongjiang ZBD Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Solid Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Vireo Growth Inc.
Tier 1ProductionApproval-Gated PipelineFlowInterface
Boji Medical & Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Varex Imaging Corporation
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Hafnia Limited
1 interpretationMinimal Tax and Interest Drag
Heilongjiang Publishing & Media Co. Ltd.
1 interpretationMinimal Tax and Interest Drag
Strait Innovation Internet Co., Ltd.
1 interpretationMinimal Tax and Interest Drag